News

  1. SGD Pharma introduces Its New Range Of Type I tubular Vials Featuring Corning's Velocity® Vial Coating Technology 2/9/2024

    SGD Pharma, global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces its new range of high-quality Type I injectable vials in tubular glass with the added external low-friction coating developed by Corning thanks to an exclusive co-development partnership. SGD Pharma’s vial-converting expertise is combined with Corning’s® proprietary glass-coating technology to improve pharmaceutical filling-line productivity and speed the global delivery of injectable treatments.

  2. Novo Holdings To Acquire CDMO Catalent Pharma Solutions For $16.5 Billion 2/5/2024

    Catalent, Inc. (NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, today announced that they have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.

  3. SGD Pharma Optimizes Global Fill And Finish Operations With The Introduction Of Its New Range Of Type I Tubular Vials Featuring Corning's Velocity® Vial Coating Technology For Enhanced Product Quality And Patient Safety 2/5/2024

    SGD Pharma, global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces its new range of high-quality Type I injectable vials in tubular glass with the added external low-friction coating developed by Corning thanks to an exclusive co-development partnership. SGD Pharma’s vial-converting expertise is combined with Corning’s® proprietary glass-coating technology to improve pharmaceutical filling-line productivity and speed the global delivery of injectable treatments.

  4. AustinPx Partners With Microsize On KinetiSol® Technology 1/31/2024

    AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally delivered small molecule drug candidates, and Microsize, a leading active pharmaceutical ingredient enhancement CDMO, today announced the strategic partnership to accelerate the commercial application of AustinPx’s KinetiSol® Technology platform. The collaboration will enable AustinPx’s clients to manufacture their late-phase clinical and commercial KinetiSol drug product intermediate at Microsize’s purpose built, FDA-inspected facility.

  5. Rob Albert Appointed Chief Executive Officer Of B. Braun Of America Inc. 1/26/2024

    The Board of Directors of B. Braun of America Inc. (“B. Braun of America”) announced today that they have appointed Rob Albert as Chief Executive Officer of B. Braun of America, succeeding Jean-Claude Dubacher who is taking on global management responsibilities, while remaining Chairman of the Board of B. Braun of America. Albert’s appointment will be effective April 1, 2024.

  6. INTEPRHEX Puts Hot-Topic Science In 2024 Event Registration Now Open | Event Program Now Online 1/22/2024

    The reimagined INTERPHEX Conference is designed to bring attendees together to solve their business challenges and to understand the science that is shaping their industries.

  7. SGD Pharma Expands Capacity Of Siliconized Glass Vials With The Announcement Of A New Siliconization Line At Its Center Of Excellence For Type I Glass In France 1/22/2024

    SGD Pharma, Global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces the opening of a new siliconization operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant. The company enhances its already extensive range of in-house services by internalizing its glass siliconization offer, further ensuring responsiveness, security of supply and improved flexibility of vial sizes.

  8. Kindeva Drug Delivery Acquires Summit Biosciences, A Specialized Nasal Drug Development And Manufacturing Organization 1/18/2024

    Kindeva Drug Delivery (“Kindeva”), a global leader in drug-device combination products, announced today that it has acquired Summit Biosciences Inc. (“Summit”), an intranasal drug-delivery contract development and manufacturing organization (CDMO), from its founding family shareholders.

  9. SGD Pharma Announces The Appointment Of Fabio Invernizzi, General Manager West Business Unit 1/17/2024

    SGD Pharma, global primary glass packaging leader, has announced the appointment of Fabio Invernizzi as its new General Manager of its West BU. The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing footprint in Europe. Fabio joins the Group Executive Committee bringing over 15 years of experience in Commercial, Marketing and Business Development at a senior level for the life science industry. He joins SGD Pharma following his last position as Vice-President and EMEA BU Head of Capsules and Health Ingredients at Lonza. Prior to that role, Fabio led the Global Commercial & Business Development activities for the Capsules & Heath Ingredients Division at Lonza.

  10. SGD Pharma Defines 2024 Growth Strategy As It Strives For Market Leadership With Investment Achievements 1/8/2024

    SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass packaging. CEO Olivier Rousseau explains that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its commercial, innovation, industrial, sustainability, HR and M&A strategies.